Anzeige
Mehr »
Dienstag, 02.09.2025 - Börsentäglich über 12.000 News
Milliardenmarkt Multiple Sklerose: Neue Therapieform könnte alles verändern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
296 Leser
Artikel bewerten:
(1)

Applied Research Works, Inc. Announces Cozeva's Achievement in NCQA's Data Aggregator Validation Program

SAN FRANCISCO / ACCESSWIRE / December 7, 2023 / Applied Research Works, Inc. (ARW), a leading provider of health data analytics and solutions, is proud to announce that its flagship product, Cozeva, has successfully passed the National Committee for Quality Assurance's (NCQA) Data Aggregator Validation (DAV) program. This significant milestone includes the exciting addition of Cozeva User Interface Entered + Enhanced Natural Language Processing (NLP) and FHIR output, marking a transformative step in healthcare data management and quality reporting.



Historically, the period between January and mid-February has been a frantic time for supplemental data submission as it was considered "non-standard". Now and in the future, Cozeva's data is recognized as "standard" after successful data validation, extending the data collection timeline to May, collectively, a game-changing advantage for healthcare providers and payers.

Top DAV Validation Impacts:

  1. Meaningful Improvements in HEDIS MY2023: Significant improvements in quality measures like blood pressure, diabetes control, and more.
  2. Reduced Chart Chase Burden for Payers: The DAV certification significantly decreases the need for payers to engage in time-consuming chart chases.
  3. Increased Provider Participation: This validation opens doors for greater provider confidence in data and participation to close care gaps.
  4. High Data Value: Shifting the expectation of the healthcare ecosystem of paying for transactional data management to actual validated data that tracks directly to performance improvement.

"The DAV certification process allows our customers to bypass the costly and time-intensive Primary Source Verification (PSV) step. By integrating Cozeva's Provider Portal Data and leveraging our advanced NLP for data validation, customers can efficiently gather clinical information, even from providers who cannot send data electronically, and provides a level of quality oversight that promotes confidence that their clinical efforts translate into credit in their measure performance." -- Alan Chuang, SVP of Customer Success.

A study by Sarawathula et al. (2023) in the Journal of the American Medical Association highlights the immense effort and cost involved in quality metric reporting, with a large academic medical center spending over 108,478 person-hours annually, primarily on data collection and validation. Cozeva's suite of solutions is designed to reduce these burdensome manual processes significantly.

By participating in the NCQA DAV program, ARW aims to alleviate the strain of HEDIS annual reporting for health systems and requestor partners. "NCQA's DAV program has shifted the burden of Primary Source Verification onto the data vendor, removing a significant stress factor for us," stated a large national health plan representative.

Cozeva's achievement in the NCQA DAV program is a testament to ARW's commitment to pioneering healthcare data management and quality reporting solutions for our customers.

About Applied Research Works, Inc:

Applied Research Works, Inc. (ARW) is a leading health information technology and analytics company offering solutions that transform data into actionable insights. Cozeva, its flagship product, is at the forefront of advancing healthcare quality and efficiency through innovative technology. Explore more at www.cozeva.com.

Contact Information

Taylor Diniz
Business Development Manager
tdiniz@cozeva.com
8082563343

SOURCE: Applied Research Works, Inc.

.



View the original press release on accesswire.com

© 2023 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.